Synapse Open Synapse
Biology

Rapport’s epilepsy drug finds surprising success in bipolar trial

BioPharma Dive · · 3 min read

Despite what some analysts described as low expectations, RAP-219 narrowly hit the main goal of a mid-stage study, results that could help it tap a billion-dollar-plus market opportunity.

Latest from BioPharma Dive